Gudlavalleti Venkata Sm, Shukla Rajan, Batchu Tripura, Malladi Bala Vidyadhar S, Gilbert Clare
Indian Institute of Public Health, Public Health Foundation of India, Kavuri Hills, Madhapur, Hyderabad 500 033,Telangana, India.
Clinical Research Department, London School of Hygiene and Tropical Medicine, London, England.
Bull World Health Organ. 2018 Oct 1;96(10):705-715. doi: 10.2471/BLT.18.212167. Epub 2018 Aug 27.
In India, 73 million people have diabetes and 3.5 million infants are born preterm. Without timely screening, there is a risk of visual loss due to diabetic retinopathy and retinopathy of prematurity in these two groups, respectively. Both conditions are emerging causes of visual impairment in India but there is no public health programme for screening or management. Pilot projects were initiated in 2014 to integrate the screening and management of these conditions into existing public health systems, particularly in rural communities and their referral networks. The World Health Organization's health systems framework was used to develop the projects and strategies were developed with all stakeholders, including the government. Both projects involved hub-and-spoke models of care units around medical schools. For diabetic retinopathy, screening was established at primary health-care facilities and treatment was provided at district hospitals. For retinopathy of prematurity, screening was integrated into sick newborn care units at the district level and treatment facilities were improved at the closest publically funded medical schools. In the first two years, there were substantial improvements in awareness, screening, treatment and partnership between stakeholders, and changes in public health policy. By March 2018, diabetic retinopathy screening was established at 50 facilities in 10 states and treatment had been improved at 10 hospitals, whereas retinopathy of prematurity screening was established at 16 sick newborn care units in district hospital in four states and treatment had been improved at six medical schools. Advocacy within state governments was critical to the success of the initiative.
在印度,有7300万人患有糖尿病,350万婴儿早产。若不及时进行筛查,这两组人群分别存在因糖尿病视网膜病变和早产儿视网膜病变而导致视力丧失的风险。这两种病症在印度正逐渐成为视力损害的病因,但却没有针对筛查或管理的公共卫生项目。2014年启动了试点项目,将这些病症的筛查和管理纳入现有的公共卫生系统,尤其是农村社区及其转诊网络。利用世界卫生组织的卫生系统框架来开展这些项目,并与包括政府在内的所有利益相关方共同制定策略。这两个项目都采用了围绕医学院校的轮辐式护理单元模式。对于糖尿病视网膜病变,在初级卫生保健机构进行筛查,并在 district 医院提供治疗。对于早产儿视网膜病变,将筛查纳入 district 级别的患病新生儿护理单元,并在距离最近的公立医学院校改善治疗设施。在头两年里,利益相关方之间在认知、筛查、治疗及合作方面有了显著改善,公共卫生政策也发生了变化。到2018年3月,10个邦的50个机构开展了糖尿病视网膜病变筛查,10家医院的治疗得到改善;而4个邦的 district 医院的16个患病新生儿护理单元开展了早产儿视网膜病变筛查,6所医学院校的治疗得到改善。在邦政府内部进行宣传对该倡议的成功至关重要。